These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 35096861)

  • 1. Varying Dose of Atropine in Slowing Myopia Progression in Children Over Different Follow-Up Periods by Meta-Analysis.
    Gan J; Li SM; Wu S; Cao K; Ma D; He X; Hua Z; Kang MT; Wei S; Bai W; Wang N
    Front Med (Lausanne); 2021; 8():756398. PubMed ID: 35096861
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and Adverse Effects of Atropine in Childhood Myopia: A Meta-analysis.
    Gong Q; Janowski M; Luo M; Wei H; Chen B; Yang G; Liu L
    JAMA Ophthalmol; 2017 Jun; 135(6):624-630. PubMed ID: 28494063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children: A Randomized Clinical Trial.
    Wei S; Li SM; An W; Du J; Liang X; Sun Y; Zhang D; Tian J; Wang N
    JAMA Ophthalmol; 2020 Nov; 138(11):1178-1184. PubMed ID: 33001210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy and safety of different doses of atropine for myopic control in children: a meta-analysis.
    Hou P; Wu D; Nie Y; Wei H; Liu L; Yang G
    Front Pharmacol; 2023; 14():1227787. PubMed ID: 37767401
    [No Abstract]   [Full Text] [Related]  

  • 5. Atropine slows myopia progression more in Asian than white children by meta-analysis.
    Li SM; Wu SS; Kang MT; Liu Y; Jia SM; Li SY; Zhan SY; Liu LR; Li H; Chen W; Yang Z; Sun YY; Wang N; Millodot M
    Optom Vis Sci; 2014 Mar; 91(3):342-50. PubMed ID: 24445721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Adverse Effects of Atropine for Myopia Control in Children: A Meta-Analysis of Randomised Controlled Trials.
    Chen C; Yao J
    J Ophthalmol; 2021; 2021():4274572. PubMed ID: 34925913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of atropine in myopic children: A meta-analysis of randomized controlled trials.
    Long H; Shi MH; Li X
    J Fr Ophtalmol; 2023 Oct; 46(8):929-940. PubMed ID: 37147148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy Comparison of 16 Interventions for Myopia Control in Children: A Network Meta-analysis.
    Huang J; Wen D; Wang Q; McAlinden C; Flitcroft I; Chen H; Saw SM; Chen H; Bao F; Zhao Y; Hu L; Li X; Gao R; Lu W; Du Y; Jinag Z; Yu A; Lian H; Jiang Q; Yu Y; Qu J
    Ophthalmology; 2016 Apr; 123(4):697-708. PubMed ID: 26826749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atropine for the treatment of childhood myopia.
    Chua WH; Balakrishnan V; Chan YH; Tong L; Ling Y; Quah BL; Tan D
    Ophthalmology; 2006 Dec; 113(12):2285-91. PubMed ID: 16996612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of 0.01% Atropine Eye Drops in Controlling Myopia Progression and Axial Elongation in Children: A Meta-analysis Based on Randomized Controlled Trials.
    Sun W; Hasebe S
    Acta Med Okayama; 2022 Aug; 76(4):457-463. PubMed ID: 36123161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myopia progression and axial elongation in Spanish children: Efficacy of atropine 0.01% eye-drops.
    Moriche-Carretero M; Revilla-Amores R; Diaz-Valle D; Morales-Fernández L; Gomez-de-Liaño R
    J Fr Ophtalmol; 2021 Dec; 44(10):1499-1504. PubMed ID: 34774348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of atropine to control myopia progression: a systematic review and meta-analysis.
    Zhao C; Cai C; Ding Q; Dai H
    BMC Ophthalmol; 2020 Dec; 20(1):478. PubMed ID: 33287746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of 0.01% and 0.02% Atropine for the Treatment of Pediatric Myopia Progression Over 3 Years: A Randomized Clinical Trial.
    Zadnik K; Schulman E; Flitcroft I; Fogt JS; Blumenfeld LC; Fong TM; Lang E; Hemmati HD; Chandler SP;
    JAMA Ophthalmol; 2023 Oct; 141(10):990-999. PubMed ID: 37261839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diluted atropine for inhibition of myopia progression in Korean children.
    Moon JS; Shin SY
    Int J Ophthalmol; 2018; 11(10):1657-1662. PubMed ID: 30364238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops.
    Chia A; Lu QS; Tan D
    Ophthalmology; 2016 Feb; 123(2):391-399. PubMed ID: 26271839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report.
    Yam JC; Li FF; Zhang X; Tang SM; Yip BHK; Kam KW; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
    Ophthalmology; 2020 Jul; 127(7):910-919. PubMed ID: 32019700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atropine in ameliorating the progression of myopia in children with mild to moderate myopia: a meta-analysis of controlled clinical trials.
    Song YY; Wang H; Wang BS; Qi H; Rong ZX; Chen HZ
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):361-8. PubMed ID: 21649523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the reports of low-concentration atropine in controlling myopia in children.
    Zhang M; Qiu W; An M; Sun Y; Zhang Z; Yu C
    J Fr Ophtalmol; 2023 Mar; 46(3):239-248. PubMed ID: 36797093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control.
    Yam JC; Jiang Y; Tang SM; Law AKP; Chan JJ; Wong E; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
    Ophthalmology; 2019 Jan; 126(1):113-124. PubMed ID: 30514630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, Safety and Acceptability of Orthokeratology on Slowing Axial Elongation in Myopic Children by Meta-Analysis.
    Li SM; Kang MT; Wu SS; Liu LR; Li H; Chen Z; Wang N
    Curr Eye Res; 2016 May; 41(5):600-8. PubMed ID: 26237276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.